These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 33672926)

  • 1. Current State of "Omics" Biomarkers in Pancreatic Cancer.
    Turanli B; Yildirim E; Gulfidan G; Arga KY; Sinha R
    J Pers Med; 2021 Feb; 11(2):. PubMed ID: 33672926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Omics Approaches to Characterize Molecular Mechanisms of Rare Ovarian Cancers: Recent Advances and Future Perspectives.
    Subbannayya Y; Di Fiore R; Urru SAM; Calleja-Agius J
    Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Detailed Catalogue of Multi-Omics Methodologies for Identification of Putative Biomarkers and Causal Molecular Networks in Translational Cancer Research.
    Vlachavas EI; Bohn J; Ückert F; Nürnberg S
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sepsis biomarkers: an omics perspective.
    Liu X; Ren H; Peng D
    Front Med; 2014 Mar; 8(1):58-67. PubMed ID: 24481820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-specific multi-omics models and the application in personalized combination therapy.
    John A; Qin B; Kalari KR; Wang L; Yu J
    Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-Omics Approaches in Colorectal Cancer Screening and Diagnosis, Recent Updates and Future Perspectives.
    Ullah I; Yang L; Yin FT; Sun Y; Li XH; Li J; Wang XJ
    Cancers (Basel); 2022 Nov; 14(22):. PubMed ID: 36428637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Omics" in oral cancer: New approaches for biomarker discovery.
    Rai V; Mukherjee R; Ghosh AK; Routray A; Chakraborty C
    Arch Oral Biol; 2018 Mar; 87():15-34. PubMed ID: 29247855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omics sciences and precision medicine in thyroid cancer.
    Dhuli K; Medori MC; Donato K; Donato K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Stuppia L; Stuppia L; Gatta V; Cristoni S; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):11-20. PubMed ID: 37994744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supervised Parametric Learning in the Identification of Composite Biomarker Signatures of Type 1 Diabetes in Integrated Parallel Multi-Omics Datasets.
    Bonnell J; Alcazar O; Watts B; Buchwald P; Abdulreda MH; Ogihara M
    Biomedicines; 2024 Feb; 12(3):. PubMed ID: 38540105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.
    Ghosh N; Dutta M; Singh B; Banerjee R; Bhattacharyya P; Chaudhury K
    Expert Rev Mol Diagn; 2016 Aug; 16(8):897-913. PubMed ID: 27267972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer Omics in Africa: Present and Prospects.
    El Jaddaoui I; Allali I; Sehli S; Ouldim K; Hamdi S; Al Idrissi N; Nejjari C; Amzazi S; Bakri Y; Ghazal H
    Front Oncol; 2020; 10():606428. PubMed ID: 33425763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omics sciences and precision medicine in melanoma.
    Medori MC; Donato K; Dhuli K; Maltese PE; Tanzi B; Tezzele S; Mareso C; Miertus J; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Beccari T; Ceccarini MR; Gisondi P; Bellinato F; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
    Clin Ter; 2023; 174(Suppl 2(6)):29-36. PubMed ID: 37994746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-omics research strategies in ischemic stroke: A multidimensional perspective.
    Li W; Shao C; Zhou H; Du H; Chen H; Wan H; He Y
    Ageing Res Rev; 2022 Nov; 81():101730. PubMed ID: 36087702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated Multi-Omics for Novel Aging Biomarkers and Antiaging Targets.
    Wu L; Xie X; Liang T; Ma J; Yang L; Yang J; Li L; Xi Y; Li H; Zhang J; Chen X; Ding Y; Wu Q
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploration of biomarkers for the diagnosis, treatment and prognosis of cervical cancer: a review.
    Arip M; Tan LF; Jayaraj R; Abdullah M; Rajagopal M; Selvaraja M
    Discov Oncol; 2022 Sep; 13(1):91. PubMed ID: 36152065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multilevel omics for the discovery of biomarkers and therapeutic targets for stroke.
    Montaner J; Ramiro L; Simats A; Tiedt S; Makris K; Jickling GC; Debette S; Sanchez JC; Bustamante A
    Nat Rev Neurol; 2020 May; 16(5):247-264. PubMed ID: 32322099
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.